3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Stomatitis
1
Head and Neck Neoplasms
1
Deglutition Disorders
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Interventions
Tomography, Optical Coherence
3
Biopsy
3
methyl 5-aminolevulinate
2
daromun
2
Mohs Surgery
2
Imiquimod
2
Aminolevulinic Acid
2
Watchful Waiting
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Solutions
1
Patient Reported Outcome Measures
1
Nivolumab
1
Niacinamide
1
Methylation
1
Itraconazole
1
Immunologic Factors
1
Hydrogen Peroxide
1
Glatiramer Acetate
1
Fluorouracil
1
Electroporation
1
Dermoscopy
1
Curettage
1
Cryotherapy
1
Coat Protein Complex I
1
Cautery
1
Capecitabine
1
Calcium Chloride
1
BF-200 ALA
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Basal Cell
×
Niacinamide
×
Clear all
NCT03769285
2023-04-06
SPRINTR-Pilot
Women's College Hospital
Phase 2
Unknown
120 enrolled